Clinical Trial Update: Effectiveness & Tolerability of Novel, Initial Triple Combination Therapy vs Conventional Therapy in Type 2 Diabetes [Phase 3]

View source ↗

Summary

Phase 3 trial comparing a novel initial triple combination therapy to conventional therapy in Type 2 diabetes mellitus. The study assesses effectiveness and tol…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Snippet

Sponsor: Korea University Anam Hospital | Conditions: Diabetes Mellitus, Type II | Phase 3 | Status: UNKNOWN